$156.92
15271 reports a wound application procedure, while A2036 identifies the Cohealyx product supplied. Report both when the product and procedure are furnished and supported.
On this page
CMS RVU26D · Effective 2026-10-01
A2036 Cohealyx matrix Medicare reimbursement rates in Nevada
A2036 reports the Cohealyx collagen dermal matrix supplied by area for wound treatment, alongside the applicable primary wound procedure. Compare A2036 office and facility rates across CMS payment localities in Nevada.
Amounts below use the non-QP conversion factor for participating physicians. These are base physician payments before claim-level adjustments, not patient costs or total hospital charges.
What does Medicare pay for A2036 in Nevada?
Nevada has 1 payment locality in this comparison. Use the service location to choose the applicable amount. These are the supported base rates for the payment area shown below, using the same CMS release.
Office / nonfacility
$127.38
1 of 1 localities have a supported rate.
Payment area: Nevada**
One mapped payment locality.
Facility setting
No supported rate
These are locality ranges, not averages or address-specific quotes. A facility-setting amount covers the physician service; it does not include a hospital’s separate bill. Choose a locality below to inspect its calculation, compare other payment areas, or price a percentage of Medicare.
Wound care products
About A2036: Cohealyx collagen dermal matrix supply
A2036 reports the Cohealyx collagen dermal matrix supplied by area for wound treatment, alongside the applicable primary wound procedure.
A2036 identifies the Cohealyx collagen dermal matrix product supplied for treatment of an open wound, with quantity measured in square centimeters. It represents the product rather than the clinician’s work preparing the wound or applying the matrix. Wound-care physicians, podiatrists, surgeons, and other clinicians may use the product in office-based wound clinics or hospital outpatient settings.
Report A2036 only with a primary procedure, such as the applicable skin-substitute application procedure; CMS treats it as an add-on and includes its payment within that procedure’s global period. Document the product used, the treated wound, the quantity supplied in square centimeters, and the related procedure. A2036 is technical-component-only; interpretation is represented by a separate code rather than included in this line.
CMS billing rules for A2036
- Global period
- Add-on code: billed only together with a primary procedure and paid within that procedure's global period.
- Professional and technical components
- Technical-component-only code: a separate code covers interpretation.
Where the value comes from
- Work RVU0.00 · 0%
- Practice expense (office) RVU3.81 · 100%
- Malpractice RVU0.00 · 0%
This summary was written with AI assistance from CMS physician fee schedule data and checked against the CMS billing rules shown here. Rates on this page come directly from CMS files.
A2036 compared with similar codes
Office rates for Nevada, from the same CMS release.
$127.38
A2038 identifies Marigen Pacto, not Cohealyx. Even though both are measured by area, select the product code matching the item furnished.
A2037
No office rateG4derm plus/suprello, pr ml
A2037 identifies G4Derm Plus/Suprello and is measured by volume. A2036 identifies Cohealyx and is measured by area.
Compare A2036 by payment locality
Find the payment area for your service address, then open its rate page for calculation inputs, release history and the percentage-of-Medicare tool. A city may cross payment-area boundaries; the ZIP lookup above helps resolve the location.
1 of 1 payment localities
Nevada** →
Office / nonfacility
$127.38
Facility
Unavailable
Need rates for a whole code list?
Fee-sheet and API access are in early access. Tell us which codes and locations your team needs.
How this local rate is calculated
Each RVU component is multiplied by its own geographic practice cost index (GPCI). The three adjusted components are added, then multiplied by the conversion factor. These are the inputs used for A2036 in Nevada**.
PPRRVU2026_Oct_nonQPP.csv
13,257
- Code
- A2036
- Physician work
- 0.00
- Practice expense
- 3.81
- Malpractice
- 0.00
GPCI2026.csv
73
- Locality
- Nevada**
- Physician work
- 1.000
- Practice expense
- 1.001
- Malpractice
- 0.833
| Component | RVU | Locality factor | Adjusted |
|---|---|---|---|
| Physician work | 0.00 | × 1.000 | 0.0000 |
| Practice expense | 3.81 | × 1.001 | 3.8138 |
| Malpractice | 0.00 | × 0.833 | 0.0000 |
| Total RVUs | 3.8138 | ||
| Conversion factor | × 33.4009 | ||
Office / nonfacility rate, Nevada**$127.38
Explore RVUs, geographic factors and the full formula
Office / nonfacility
| Component | RVU | Local GPCI |
|---|---|---|
| Work | 0 | 1 |
| Practice expense | 3.81 | 1.001 |
| Malpractice | 0 | 0.833 |
(0 × 1 + 3.81 × 1.001 + 0 × 0.833) × $33.4009 = $127.38
The office and facility calculations use their respective practice-expense RVUs. The facility amount here is the physician fee, not a separate hospital or facility bill.
A2036 billing questions
Does A2036 report the wound application procedure?
No. A2036 represents the Cohealyx product; report the applicable primary procedure separately for the clinician’s wound treatment and application.
Can A2036 be billed without a primary procedure?
No. CMS identifies A2036 as an add-on that must be billed with a primary procedure.
How is the product quantity reported?
The code is measured per square centimeter. Documentation should support the quantity of Cohealyx supplied for the treated wound.
Does A2036 include interpretation?
No. CMS classifies A2036 as technical-component-only, with interpretation represented by a separate code.
How does its payment relate to the primary procedure?
CMS places A2036 payment within the primary procedure’s global period.
Where these rates come from
FeeBase calculates base physician payments from CMS work, practice-expense, and malpractice RVUs, adjusted by each locality’s geographic indices and the applicable conversion factor. Unavailable or separately priced services are labeled rather than assigned a made-up amount.
Source: RVU26D. Effective 2026-10-01 through the day before 2027-01-01.
13,254A2033,,"Myriad morcells, 4 mg",C,,0.00,0.00,,0.00,,0.00,0.00,0.00,3,XXX,0.00,0.00,0.00,9,9,9,9,9,9,,33.4009,09,0,99,0.00,0.00,0.00
13,255A2034,,"Found drs solo, per sq cm",A,,0.00,3.81,,3.81,NA,0.00,3.81,3.81,3,ZZZ,0.00,0.00,0.00,0,0,0,0,0,9,,33.4009,09,0,99,0.00,0.00,0.00
13,256A2035,,Corpl p therac p allac p mg,C,,0.00,0.00,,0.00,,0.00,0.00,0.00,3,XXX,0.00,0.00,0.00,9,9,9,9,9,9,,33.4009,09,0,99,0.00,0.00,0.00
13,257A2036,,Cohealyx col dml mx pr sq cm,A,,0.00,3.81,,3.81,NA,0.00,3.81,3.81,3,ZZZ,0.00,0.00,0.00,0,0,0,0,0,9,,33.4009,09,0,99,0.00,0.00,0.00
13,258A2037,,"G4derm plus/suprello, pr ml",C,,0.00,0.00,,0.00,,0.00,0.00,0.00,3,XXX,0.00,0.00,0.00,9,9,9,9,9,9,,33.4009,09,0,99,0.00,0.00,0.00
13,259A2038,,"Marigen pacto, per sq cm",A,,0.00,3.81,,3.81,NA,0.00,3.81,3.81,3,ZZZ,0.00,0.00,0.00,0,0,0,0,0,9,,33.4009,09,0,99,0.00,0.00,0.00
13,260A2039,,"Innovamatrix fd, per sq cm",A,,0.00,3.81,,3.81,NA,0.00,3.81,3.81,3,ZZZ,0.00,0.00,0.00,0,0,0,0,0,9,,33.4009,09,0,99,0.00,0.00,0.00
7005302,MO,99,REST OF MISSOURI,1.000,0.862,0.974
7103202,MT,01,MONTANA**,1.000,1.000,0.998
7205402,NE,00,NEBRASKA,1.000,0.923,0.378
7301312,NV,00,NEVADA**,1.000,1.001,0.833
7414312,NH,40,NEW HAMPSHIRE,1.000,1.041,0.875
7512402,NJ,01,NORTHERN NJ,1.063,1.160,1.068
7612402,NJ,99,REST OF NEW JERSEY,1.040,1.092,1.097